NovaBridge Biosciences (NBP) Gains from Investment Securities (2017 - 2025)
NovaBridge Biosciences (NBP) reported Gains from Investment Securities of $28.4 million for Q4 2025, up 1317.86% quarter-over-quarter from $2.0 million in Q4 2023.
NovaBridge Biosciences (NBP) Gains from Investment Securities (2017 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 7 years of Gains from Investment Securities data on file, last reported at $28.4 million in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $28.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $28.4 million (changed N/A YoY), and the FY2025 annual result was $28.4 million, up 257894.14% from the prior year.
- Gains from Investment Securities improved to $28.4 million in Q4 2025 per NBP's latest filing, from $2.0 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $28.4 million in Q4 2025 and troughed at $20945.3 in Q4 2021.
- A 4-year average of $7.6 million and a median of $1.1 million in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2021 and 2023: Gains from Investment Securities surged 102.76% in 2021, then soared 1782.2% in 2023.
- A 4-year view of Gains from Investment Securities shows it stood at $20945.3 in 2021, then soared by 407.32% to $106259.3 in 2022, then soared by 1782.2% to $2.0 million in 2023, then surged by 1317.86% to $28.4 million in 2025.
- Business Quant data shows NBP's Gains from Investment Securities at $28.4 million in Q4 2025, $2.0 million in Q4 2023, and $106259.3 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.36 Mn |
| Dec 31, 2025 | 28.36 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 106,259.28 |
| Dec 31, 2022 | 106,259.28 |
| Dec 31, 2021 | 20,945.28 |
| Dec 31, 2021 | 20,945.28 |
| Dec 31, 2020 | -760,049.53 |
| Dec 31, 2020 | -760,049.53 |
| Sep 30, 2020 | 725,429.16 |
| Sep 30, 2020 | 725,429.16 |
| Dec 31, 2019 | 789,850.24 |
| Dec 31, 2019 | 789,850.24 |
| Sep 30, 2019 | 5.46 Mn |
| Sep 30, 2019 | 5.46 Mn |
| Dec 31, 2017 | 19,648.46 |
| Dec 31, 2017 | 19,648.46 |